169307 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; General methods of protein analysis not limited to specific proteins or families of proteins; Determination of free amino acids Assays for specific amino acids
ESTIMATING GLOMERULAR FILTRATION RATES IN FELINES
#2BIOMOLECULAR DETECTION METHOD AND DETECTION SYSTEM THEREOF
#3METHODS AND COMPOSITIONS FOR TARGETING SERINE DEHYDRATASE
#4METHOD FOR PROVIDING INFORMATION FOR BRAIN DOPING DIAGNOSIS
#5Bio-Inspired Proline Sensors for Diagnosis and Surveillance of Stress in Living Systems
#6METABOLIC BIOMARKERS FOR ASSESSING FRIEDREICH'S ATAXIA IN A SUBJECT
#7METHOD FOR DIAGNOSING ENDOMETRIOSIS IN A SUBJECT
#8Methods for Detecting Renal Disease
#9Biomarkers for Neurodegenerative Disease
#10Methods for Detecting Renal Disease
#11ANALOGS AND CONJUGATES OF ß-AMINOISOBUTYRIC ACID (BAIB)
#12METHOD FOR DETERMINING DEPRIVATION OF OUTER MEMBRANE OF CYANOBACTERIUM, APPARATUS FOR DETERMINING DEPRIVATION OF OUTER MEMBRANE OF CYANOBACTERIUM, AND PROGRAM
#13MARKER AND DEVICE FOR DIAGNOSING OVERALL HEALTH STATUS OF INDIVIDUAL
#14METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING TRYPTOPHAN AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF
#15Method of evaluating lifestyle-related disease indicator, lifestyle-related disease indicator-evaluating apparatus, lifestyle-related disease indicator-evaluating method, lifestyle-related disease indicator-evaluating program product, lifestyle-related disease indicator-evaluating system, and information communication terminal apparatus
#16HANDHELD BLOOD MEASURING DEVICE USING NANOPOROUS ANODIC ALUMINUM OXIDE SUBSTRATE AND APPLICATION OF SAME
#17MEANS AND METHODS FOR SINGLE MOLECULE PEPTIDE SEQUENCING
#18AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#19EVALUATING METHOD FOR RELATIVE PHARMACOLOGICAL ACTIONS OF COMBINATIONS OF IMMUNE CHECKPOINT INHIBITORS AND ANTICANCER DRUGS AS COMBINATION DRUGS COMPARED WITH PHARMACOLOGICAL ACTIONS OF IMMUNE CHECKPOINT INHIBITORS ALONE, CALCULATING METHOD, EVALUATING APPARATUS, CALCULATING APPARATUS, EVALUATING PROGRAM, CALCULATING PROGRAM, RECORDING MEDIUM, EVALUATING SYSTEM, AND TERMINAL APPARATUS
#20BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders
#21EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS
#22METHOD FOR ANALYZING LEUCINE AND ISOLEUCINE, AS WELL AS DEVICE FOR ANALYZING LEUCINE AND ISOLEUCINE
#23BIOSENSOR, BIOSENSOR COMPONENTS, AND USE THEREOF
#24METHOD FOR ANALYZING AMINO ACIDS AND/OR ACYLCARNITINES
#25ELECTROCHEMICAL SENSOR FOR DETECTING AND CHARACTERIZING A BIOLOGICAL MATERIAL
#26METHOD FOR DETECTING AND/OR QUANTIFYING MOOD DISORDER AND/OR IMPROVEMENTS OF THE MOOD DISORDER STATUS USING N-ACETYL-L-TRYPTOPHAN AS BIOMARKER AND IMPROVED METHODS AND COMPOSITIONS THEREOF
#27METABOLITE BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PACREATIC CYSTS
#28Oxidative Cyclization Reagents for Chemoselective Tryptophan Bioconjugation
#29METHOD FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER, SYSTEM FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER
#30METHOD FOR QUANTIFYING PHENYLALANINE IN BLOOD, AND MEASUREMENT KIT USED THEREFOR
#31Homogenous Immunoassay with Compensation for Background Signal
#32DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS ASSOCIATED WITH ALTERED METABOLIC PATHWAYS
#33USE OF GLYCOPROTEIN ACETYLS FOR DETERMINING THE RISK OF DEVELOPING A GALLBLADDER DISORDER
#34Handheld biomarker measuring device using nanoporous anodic aluminum oxide substrate and application of same
#35DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS USING ALTERED RATIOS OF METABOLIC CONCENTRATIONS
#36ODD CHAIN FATTY ACID THERAPY FOR THE TREATMENT OF MITOCHONDRIAL DISEASES
#37METHODS FOR PROVIDING AND DETERMINING AN EFFICACIOUS WEIGHT LOSS DIET FOR A CANINE
#38Genetically encoded biosensors
#39DETECTION OF A RELAPSE IN A MULTIPLE SCLEROSIS PATIENT
#40METHOD OF ISOLATING AND MEASURING DESMOSINE AND ISODESMOSINE IN ELASTIN
#41Non-enzymatic electrochemical sensor for measuring analytes
#42Biomarkers Related to Immune Checkpoint Inhibitor Therapy and Methods of Using the Same
#43METHODS FOR IDENTIFICATION, STRATIFICATION, AND TREATMENT OF CNS DISEASES
#44METHODS OF DETECTING ISOASPARTIC ACID
#45Gold nanoporous anodic aluminum oxide substrate of at-home blood phenylalanine measuring device for phenylketonuria and applications thereof
#46Fabrication of gold nanoporous anodic aluminum oxide substrate of at-home blood phenylalanine measuring device for phenylketonuria
#47Fluorescent Biosensor for Rapid Determination of L-arginine
#48TEST KIT AND METHOD OF DETERMINING TRYPTOPHAN IN EXTRACTS OF FAECAL SAMPLES
#49TRYPTOPHAN OPTICAL PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF
#50ARGININE FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#51HISTAMINE BINDING POLYPEPTIDES AND USES THEREOF
#52METHOD OF DETECTING LUNG CANCER
#53NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS
#54Means and methods for single molecule peptide sequencing
#55METHODS OF DETECTING CLOSTRIDIUM DIFFICILE INFECTIONS
#56Single-chain polymer-based target receptors for use in electrochemical detection of target analytes
#57Method for detecting l-serine based on cysteine desulfurase
#58REAGENTS FOR RAPID CHIRAL LABELING AND ANALYSIS OF AMINE CONTAINING ENANTIOMERS
#59DETECTION OF SYMMETRICAL DIMETHYLARGININE
#60SET OF BIOMARKERS FOR THE DIAGNOSIS OF BRUGADA SYNDROME
#61AMINO ACID ANALYSIS METHOD
#62At-home blood phenylalanine measuring device for phenylketonuria and applications thereof
#63DIAGNOSTICS
#64METHOD AND SYSTEM FOR ESTIMATING RENAL FUNCTION
#65USE OF PAK4 AND CRTC1 FOR TREATMENT OR DIAGNOSIS OF BRAIN DEGENERATIVE DISEASE
#66Methods and kits for the derivatization of a biogenic amine
#67MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT
#68Method for analyzing test substance, analyzer, training method, analyzer system, and analysis program
#69Modular Chemical Probe For Detection Of Amino Acid Citrulline In Physiological Samples
#70METHODS FOR PREDICTING AND TREATING CARDIAC DYSFUNCTION
#71Peptide aptamer for specific recognition of arginine and its application
#72MINIMALLY INVASIVE CONTINUOUS ANALYTE MONITORING FOR CLOSED-LOOP TREATMENT APPLICATIONS
#73BLOOD INDICATORS OF ALZHEIMER'S DISEASE
#74METHOD FOR ASSISTING EVALUATION OF CONDITION OF KIDNEYS, SYSTEM FOR EVALUATING CONDITION OF KIDNEYS, AND PROGRAM FOR EVALUATING CONDITION OF KIDNEYS
#75Methods for Detecting Symmetrical Dimethylarginine
#76BIOMARKER DETECTION FOR CANCER DIAGNOSIS AND PROGNOSIS
#77AN ELECTROCHEMICAL SENSOR FOR DETECTING AND CHARACTERIZING A BIOLOGICAL MATERIAL
#78MONITORING AND ALTERING THE GUT MICROBIOME IN DISEASE
#79Examination method for dementia or risk thereof
#80Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease
#81METHOD FOR ASSISTING EVALUATION OF RENAL PATHOLOGICAL CONDITIONS, SYSTEM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS AND PROGRAM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS
#82Methods for Detecting Renal Disease
#83REAGENTS AND METHODS FOR DETECTING PROTEIN LYSINE LACTYLATION
#84Genetically encoded biosensors
#85Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
#86Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
#87A LABELLING METHOD TO DISTINGUISH ISOBARIC AMINO ACIDS AND AMINO ACID COMBINATIONS
#88BIOMARKERS FOR MITOCHONDRIAL DISEASES AND RELATED METHODS
#89METHOD FOR DETERMINING GLOMERULAR FILTRATION ABILITY
#90MARKER FOR DETERMING CRITICAL STAGE KIDNEY DISEASE
#91Methods of selecting subjects for treatment with metabolomic modulators
#92RENAL FUNCTION MAINTENANCE AND PROTECTION AGENT, AND METHOD FOR EVALUATING EFFECT THEREOF
#93COMPOSITIONS AND METHODS TARGETING GLUTAMINE AND ITS METABOLISM FOR DIAGNOSING AND TREATING CANCER AND THERAPY-ASSOCIATED SIDE EFFECTS
#94LYSINE REACTIVE PROBES AND USES THEREOF
#95ANALOGS AND CONJUGATES OF BETA-AMINOISOBUTYRIC ACID (BAIB)
#96APPARATUS FOR ANALYSIS OF EGGS
#97Biomarkers for assessing breast cancer
#98METHOD FOR SCREENING AGENTS PROMOTING SKIN BARRIER FUNCTION AND METHOD FOR EVALUATING SKIN BARRIER FUNCTION TAKING EPIDERMAL SERINE RACEMASE AND/OR D-SERINE LEVEL AS INDICATOR
#99Methods and Diagnostics for Cancer Detection and Treatment Monitoring
#100AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#101METHODS AND SYSTEMS FOR DETERMINING STATES OF MOLECULE FOLDING, CONFORMATION, OR INTERACTION AND APPLICATIONS FOR DETECTING PROTEOPATHIES
#102VARIANT LIBRARIES OF THE IMMUNOLOGICAL SYNAPSE AND SYNTHESIS THEREOF
#103Anti-hypusine antibodies and uses thereof
#104Non-invasive analysis of embryo metabolites
#105METHODS FOR ASSESSING THE NEED FOR AND THE EFFECTIVENESS OF THERAPY WITH ANTIOXIDANTS
#106FORMULATIONS COMPRISING MERCURY-CONTAINING REAGENTS FOR DETECTING DISEASE
#107Homogenous immunoassay with compensation for background signal
#108Genetically encoded biosensors
#109METHODS OF TREATING UREA CYCLE DISORDERS
#110Single-chain polymer-based target receptors for use in electrochemical detection of target analytes
#111METABOLIC SIGNATURES ASSOCIATED WITH DIAGNOSIS, DISEASE PROGRESSION, AND IMMUNOLOGICAL RESPONSE TO TREATMENT OF PATIENTS WITH COVID-19
#112Method of examining diabetic complication
#113NON-ENZYMATIC ELECTROCHEMICAL SENSOR FOR MEASURING ANALYTES
#114Feeding management system and feeding management method
#115Detection kit for quaternary ammonium compound having γ-carboxyl group
#116High-throughput single molecule protein identification
#117Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
#118Polypeptides for the treatment of diseases
#119USE OF TRYPTOPHAN DERIVATIVES FOR PROTEIN FORMULATIONS
#120KDAC VARIANTS AND USES THEREOF
#121Means and methods for single molecule peptide sequencing
#122Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
#123Mass spectrometry method for detection and quantitation of metabolites
#124METHODS OF ASSESSING THE NEED FOR AND THE EFFECTIVENESS OF THERAPY WITH ANTIOXIDANTS
#125Methods for detecting lacosamide by mass spectrometry
#126POINT-OF-CARE DEVICE FOR THE QUANTITATIVE DETERMINATION OF BRANCHED-CHAIN AMINO ACIDS IN BIOLOGICAL SAMPLES
#127BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE
#128Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
#129Genetically encoded biosensors
#130MARKER FOR EARLY DIAGNOSIS OF KIDNEY FAILURE
#131MARKER FOR EARLY DIAGNOSIS OF KIDNEY FAILURE
#132GENETICALLY ENCODED BIOSENSORS
#133Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator
#134SH2 DOMAIN VARIANTS
#135Methods and kits for the derivatization of a biogenic amine
#136Materials and methods for detection and quantification of β-N-methylamino-L-alanine
#137PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS
#138Detection of symmetrical dimethylarginine
#139AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#140Method for quantifying amino acid and amino acid quantification kit
#141Methods for determining molecule folding associated with proteopathies
#142USE OF PAK4 AND CRTC1 FOR TREATMENT OR DIAGNOSIS OF BRAIN DEGENERATIVE DISEASE
#143LYSINE REACTIVE PROBES AND USES THEREOF
#144Genetically encoded biosensors
#145METHOD OF QUANTITATIVE DETERMINATION OF SARCOSINE IN A BIOLOGICAL SAMPLE
#146Methods and Diagnostics for Cancer Detection and Treatment Monitoring
#147Methods for Detecting Symmetrical Dimethylarginine
#148Anti-hypusine antibodies and uses thereof
#149Pathway specific markers for diagnosing irritable bowel syndrome
#150Mass defect-based multiplex dimethyl pyrimidinyl ornithine (DiPyrO) tags for high-throughput quantitative proteomics and peptidomics
#151BARCODED RAPID ASSAY PLATFORM USEFUL FOR EFFICIENT ANALYSIS OF CANDIDATE MOLECULES AND METHODS OF MAKING AND USING THE PLATFORM
#152Biomarkers for Diagnosing Liver Disease
#153METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS
#154Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto
#155Methods for detecting lacosamide by mass spectrometry
#156Genetically encoded biosensors
#157Method for profiling protein methylation
#158METHODS OF CHARACTERIZING ADRENOCORTICAL TUMORS
#159Method of detecting lung cancer
#160Variant libraries of the immunological synapse and synthesis thereof
#161Immunoassays of s-adenosylmethionine and methylation index in personalized medicine and health evaluation
#162METHOD FOR CHARACTERISING IONS
#163PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS
#164Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease
#165Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios
#166Analysis of amino acid copolymer compositions
#167METHODS FOR DETECTING RENAL DISEASE
#168Small molecule metabolites for the diagnosis of bacterial vaginosis and assessment of disease risk
#169METHOD OF DIGITIZING NUTRITIONAL STATUS, MUSCLE TURNOVER, AND RISK ASSESSMENT
#170Detection method for quaternary ammonium compound having γ-carboxyl group
#171Compositions and methods for metabolic profiling in subjects with heart failure with preserved ejection fraction
#172Method for the in vitro identification of drug-resistant epilepsy
#173IPA as a protective agent
#174Formulations comprising mercury-containing reagents for detecting disease
#175Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#176METHODS OF TREATING UREA CYCLE DISORDERS
#177EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS
#178Genetically encoded biosensors
#179METHODS OF TREATING UREA CYCLE DISORDERS
#180METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS
#181METHODS OF TREATING UREA CYCLE DISORDERS
#182METHODS OF TREATING UREA CYCLE DISORDERS
#183USE OF 5-METHOXYTRYPTOPHAN AS DIAGNOSTIC AGENT OF INFLAMMATORY DISEASES
#184CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE
#185Pathway specific markers for diagnosing irritable bowel syndrome
#186Biomarkers for assessing breast cancer
#187METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS
#188USE OF TRYPTOPHAN DERIVATIVES FOR PROTEIN FORMULATIONS
#189Non-enzymatic electrochemical sensor for measuring analytes
#190DETECTION OF PROTEIN ARGININE DEMETHYLASE ACTIVITY
#191DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF AMINOACIDOPATHIES
#192Diagnostics
#193Biomarkers for assessing HIV
#194Methods for detecting lacosamide by mass spectrometry
#195Methods and diagnostics for cancer detection and treatment monitoring
#196Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator
#197BIOMARKERS FOR ASSESSING KIDNEY DISEASES
#198METHODS FOR DETECTING, DIAGNOSING AND TREATING TRAUMATIC BRAIN INJURY
#199AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#200Compositions and methods for inhibiting arginase activity
#201BLOOD-BASED BIOMARKER FOR CANCER
#202Methods of assessing the need for and the effectiveness of therapy with antioxidants
#203Methods of diagnosing bipolar disorders and screening for therapeutic compounds
#204Methods for Diagnosing Onset and Monitoring Progression of Huntington's Disease
#205Marker for early diagnosis of kidney failure
#206ANALYSIS OF AMINO ACID COPOLYMER COMPOSITIONS
#207Compositions and method for destabilizing, altering, and dispersing biofilms
#208Methods of detecting and measuring glutamine and analogues thereof, and methods related thereto
#209Homogenous immunoassay with compensation for background signal
#210Blood based biomarkers for diagnosing atherosclerotic coronary artery disease
#211DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE
#212Methods for detecting renal disease
#213Device and methods of using device for detection of aminoacidopathies
#214Pathway specific markers for diagnosing irritable bowel syndrome
#215Compositions and methods related to recombinant antibodies to histone posttranslational modifications
#216Pathway specific assays for predicting irritable bowel syndrome diagnosis
#217Method for determining cell state and autoanalyzer using said method
#218METHODS OF TREATING UREA CYCLE DISORDERS
#219Analysis of amino acid copolymer compositions
#220Immunoassays of S-adenosylmethionine and methylation index in personalized medicine and health evaluation
#221METABOLIC PROFILES
#222Hexanoylglycine as biomarker for the predisposition for weight gain and obesity
#223Analysis of amino acid copolymer compositions
#224Biomarkers for differentiating between non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD)
#225PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS
#226Indole lactic acid or a mixture of indole lactic acid and indole-3-propionic acid for treatment of Huntington's disease
#227Labeled chiral alpha-hydroxy ketoacid derivatives, a process for preparing said derivatives and their use
#228NOVEL METHOD FOR THE DIAGNOSIS OF ENDOMETRIOSIS
#229SH2 domain variants
#230QUANTITATION OF BIOMARKERS FOR THE DETECTION OF PROSTATE CANCER
#231METHODS FOR DIAGNOSING CHRONIC VALVULAR DISEASE
#232Genetically encoded biosensors
#233HYDROXY-SPHINGOMYELIN 22:1 AS A BIOMARKER FOR HEALTHY AGING
#2349-oxo-HODE as a biomarker for healthy aging
#235Device and method for analyzing target
#236Method for diagnosing stomach cancer using change of tryptophan metabolism
#237Method for analyzing formyl glycine residue
#238Modified leucine dehydrogenase
#239Compositions and methods for analyzing histidine phosphorylation
#240Methods for detecting lacosamide by mass spectrometry
#241Method for quantifying amino acids with pyrophosphate
#242Method of detecting thalassemia by optical analysis of blood components
#243Media comprising a glutamine biosensor and methods of use thereof
#244Methods for detecting symmetrical dimethylarginine
#245Means and methods for assessing increased peroxisomal proliferation
#246System and method for quantifying fragile X mental retardiation 1 protein in tissue and blood samples
#247IPA as a therapeutic agent and a biomarker for disease risk for Huntington's disease
#248Method of evaluating fatty liver related disease, fatty liver related disease-evaluating apparatus, fatty liver related disease-evaluating method, fatty liver related disease-evaluating program product, fatty liver related disease-evaluating system, information communication terminal apparatus, and method of searching for prophylactic/ameliorating substance for fatty liver related disease
#249Screening for neurotoxic amino acid associated with neurological disorders
#250Analysis of amino acid copolymer compositions
#251Molecularly imprinted conducting polymer film based aqueous amino acid sensors
#252Methods of therapeutic monitoring of phenylacetic acid prodrugs
#253Methods for detecting symmetrical dimethylarginine
#254IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
#255Diagnostic tools for charcot-marie-tooth disease
#256Homoarginine as a biomarker for the risk of mortality
#257Biomarkers for diagnosing liver disease
#258Differentiation of isobaric amino acids and other species
#259Sulfur-containing amino acid derivative
#260AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#261IMMUNOASSAY OF CARBOXYMETHYLARGININE
#262METHOD FOR THE DETECTION OF PREDIABETES
#263DETECTING ISOMERS USING DIFFERENTIAL DERIVATIZATION MASS SPECTROMETRY
#264EFFECTS OF IDH1 AND IDH2 MUTATIONS ON THE CELLULAR METABOLOME
#265Synthetic Receptors for Identification of Protein Posttranslation Modifications
#266Use of mimecan in the assessment of heart failure
#267METABOLIC PROFILES
#268Compositions, antibodies, asthma diagnosis methods, and methods for preparing antibodies
#269Cellular assay employing detectable protein
#270Method of evaluating obesity, obesity-evaluating apparatus, obesity-evaluating method, obesity-evaluating system, obesity-evaluating program product, recording medium, and information communication terminal apparatus
#271DOSING AND MONITORING PATIENTS ON NITROGEN-SCAVENGING DRUGS
#272Hepatic disease-evaluating apparatus, hepatic disease-evaluating method, hepatic disease-evaluating system, hepatic disease-evaluating program and recording medium
#273Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#274Biomarker-Based Methods For Formulating Compositions That Improve Skin Quality And Reduce The Visible Signs Of Aging In Skin
#275LIVER DISEASE MARKER, METHOD AND APPARATUS FOR MEASURING THE SAME, AND METHOD FOR ASSAYING PHARMACEUTICAL PREPARATION
#276Methods For Improving Skin Quality
#277Methods For Improving Skin Quality
#278Methods For Improving Skin Quality
#279Methods For Improving Skin Quality
#280Methods For Improving Skin Quality
#281Biomarkers of inflammation in Bruch's membrane of the human retina
#282Immunoassays for citrullinated proteins
#283Immunoassay for detection of neurotoxic amino acid associated with neurological disorders
#284BLOOD MARKERS OF TRANSPLANTED INTESTINE REJECTION
#285Detecting leucine and its isomers using differential esterification mass spectrometry
#286Screening for neurotoxic amino acid associated with neurological disorders
#287METHODS FOR MODIFYING, ISOLATING, DETECTING, VISUALIZING, AND QUANTIFYING CITRULLINATED AND/OR HOMOCITRULLINATED PEPTIDES, POLYPEPTIDES AND PROTEINS
#288Methods and compositions comprising non-natural amino acids
#289Method of evaluating prostatic disease
#290Means and methods for assessing increased peroxisomal proliferation
#291Carbamylated proteins and risk of cardiovascular disease
#292Methylarginine detection in cells and tissues
#293Methods of determining levels of free amino acids and dipeptides and diagnosing Alzheimer's disease
#294Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
#295Methods of distinguishing between glutamine formed by cataplerosis or proteolysis
#296METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION
#297Method of evaluating gastric cancer, gastric cancer-evaluating apparatus, gastric cancer-evaluating method, gastric cancer-evaluating system, gastric cancer-evaluating program and recording medium
#298Imprinted polymers with affinity for phosphorylated peptides and proteins
#299Marker for determination of sensitivity to anti-cancer agent
#300Analysis of amino acid copolymer compositions